Invivyd Announces Positive 180-day Clinical Efficacy Data From CANOPY Phase 3 Trial Of Pemivibart

RTTNews | 336 dagar sedan
Invivyd Announces Positive 180-day Clinical Efficacy Data From CANOPY Phase 3 Trial Of Pemivibart

(RTTNews) - Biopharmaceutical company Invivyd, Inc. (IVVD) announced Tuesday positive 180-day clinical efficacy data from the company's ongoing CANOPY Phase 3 clinical trial of pemivibart, a half-life extended investigational monoclonal antibody (mAb), for the pre-exposure prophylaxis (PrEP) of COVID-19.

The exploratory clinical efficacy data in Cohort B, a placebo-controlled cohort of all-comer immunocompetent individuals, showed a relative risk reduction of 84% with pemivibart compared to placebo in the likelihood of trial participants contracting confirmed symptomatic COVID-19, with no hospitalizations or deaths due to COVID-19 reported.

Cohort B participants treated with pemivibart experienced a 1.9% rate of symptomatic COVID-19 across a 180-day time period, whereas Cohort B participants in the placebo arm experienced an 11.9% rate of symptomatic COVID-19, a robust attack rate for the trial. Cases of COVID-19 observed in the pemivibart arm were mild or moderate in severity.

Additionally, in Cohort A, the single-arm immunocompromised cohort of the trial, pemivibart demonstrated a 3% rate of confirmed symptomatic COVID-19 over the 180-day period. Cases of COVID-19 observed in this cohort were also mild or moderate in severity.

These exploratory data support the concept of potential protection observed with pemivibart, aligned with expectations of a highly active prophylactic monoclonal antibody in this population.

The safety profile of pemivibart in the second half of the assessed 180-day time period remained consistent with previously disclosed CANOPY clinical trial data.

The 180-day clinical efficacy exploratory data announced today complements the initial clinical efficacy exploratory data demonstrating potential signals of clinical protection from symptomatic COVID-19 shared previously.

read more
Invivyd Appoints William Duke As New CFO

Invivyd Appoints William Duke As New CFO

Biopharmaceutical company Invivyd, Inc. (IVVD) announced Tuesday the appointment of William Duke as Chief Financial Officer. Duke will lead Invivyd's financial strategy to support the company's continued growth.
RTTNews | 693 dagar sedan
Swiss Market Closes On Firm Note

Swiss Market Closes On Firm Note

The Switzerland market shrugged off a somewhat shaky start and climbed higher on Tuesday with investors mostly reacting to corporate earnings updates, and looking ahead to monetary policy announcement from the Federal Reserve and closely following trade talks.
RTTNews | 50 minuter sedan
European Stocks Close Higher As Investors React To Earnings

European Stocks Close Higher As Investors React To Earnings

European stocks closed on a firm note on Tuesday as investors reacted to a slew of earnings announcements from the region, and looked ahead to monetary policy announcements from some leading central banks, including the U.S. Federal Reserve.
RTTNews | 1h 12minuter sedan
TSX Pares Some Gains After Hitting New High; Celestica Rises On Strong Results

TSX Pares Some Gains After Hitting New High; Celestica Rises On Strong Results

The Canadian market is up in positive territory a little past noon on Tuesday, supported by gains in technology, real estate, healthcare and consumer staples sectors. In addition to following the developments on the trade front, investors are also looking ahead to the monetary policy announcements from the Bank of Canada and the Federal Reserve.
RTTNews | 2h 11minuter sedan
U.S. Consumer Confidence Modestly Improves In July

U.S. Consumer Confidence Modestly Improves In July

Consumer confidence in the U.S. saw a modest improvement in the month of July, according to a report released by the Conference Board on Tuesday. The Conference Board said its consumer confidence index rose to 97.2 in July after falling to a revised 95.2 in June.
RTTNews | 4h 30minuter sedan
Bay Street Seen Opening Slightly Higher

Bay Street Seen Opening Slightly Higher

Canadian shares may open higher Tuesday morning, riding on firm oil and metal prices. Investors, awaiting trade talks between Canadian and U.S. officials, also look ahead to Bank of Canada's interest rate decision, due on Wednesday.
RTTNews | 5h 50minuter sedan